Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling to characterize anticancer drug sensitivity.

James K Breaux1, Gerrit Los

  • 1Rebecca and John Moores UCSD Cancer Center, University of California-San Diego, La Jolla, USA.

Methods in Molecular Medicine
|May 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.

Nature communications·2025
Same author

RSK1 dependency in FLT3-ITD acute myeloid leukemia.

Blood cancer journal·2024
Same author

The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials.

Expert opinion on investigational drugs·2020
Same author

RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.

Expert opinion on therapeutic targets·2019
Same author

Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

Cancer letters·2018
Same author

Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.

Frontiers of medicine·2013
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

This study details a cDNA microarray protocol to analyze gene expression and predict anticancer drug sensitivity. This method aids in understanding treatment responses and optimizing cancer therapies.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Anticancer drug sensitivity varies significantly among patients.
  • Gene expression profiling offers a potential method to predict drug response.
  • Standardized protocols are needed for reliable gene expression analysis.

Purpose of the Study:

  • To present a detailed protocol for using cDNA microarrays to characterize anticancer drug sensitivity.
  • To guide researchers in experimental design and preliminary studies for gene expression profiling.

Main Methods:

  • The protocol covers drug exposure, RNA isolation, and sample labeling.
  • It includes cDNA microarray hybridization, data processing, and statistical analysis.
  • Key experimental design considerations are also discussed.

Related Experiment Videos

Main Results:

  • The chapter provides a comprehensive workflow for gene expression profiling.
  • It enables the characterization of gene expression patterns associated with drug sensitivity.
  • Recommendations for preliminary experiments are included.

Conclusions:

  • This protocol facilitates the assessment of anticancer drug sensitivity through gene expression analysis.
  • It serves as a valuable resource for researchers in cancer pharmacology and molecular oncology.
  • The methodology supports the development of personalized cancer treatment strategies.